Granite Point Capital Management’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-195
| Closed | -$621K | – | 154 |
|
|
2021
Q2 | $621K | Sell |
195
-326
| -63% | -$1.04M | 0.02% | 112 |
|
|
2021
Q1 | $2.31M | Buy |
+521
| New | +$2.31M | 0.09% | 50 |
|
|
2018
Q2 | – | Hold |
0
| – | -$163K | – | 127 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | -$250K | – | 89 |
|
|
2017
Q4 | $250K | Hold |
1
| – | – | 0.02% | 88 |
|
|
2017
Q3 | $135K | Hold |
1
| – | – | 0.03% | 90 |
|
|
2017
Q2 | $157K | Hold |
1
| – | – | 0.04% | 91 |
|
|
2017
Q1 | $179K | Hold |
1
| – | – | 0.05% | 77 |
|
|
2016
Q4 | $264K | Buy |
+1
| New | +$264K | 0.21% | 70 |
|